Bionsight is a drug discovery company that integrates the power of chemoproteomics and AI technologies to facilitate target identification and off-target profiling within the drug development process. We offer a chemoproteomics platform named Javelin, capable of identifying thousands of proteins, thereby enabling comprehensive protein-ligand interaction mapping on a proteome-wide scale. This state-of-the-art method provides numerous benefits for drug discovery. It empowers us to uncover multiple interactions, provides broad scope applicability to diverse targets, opens the potential to delve into the mechanisms of action and side effects, and presents a cutting-edge strategy to address previously "undruggable" targets.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 58 Wangsimni-Ro, Seongdong-Gu, Seoul, Seoul,seoul 04778,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.bionsight.com/
- Keywords
- Chemoproteomics, AI, ML.
- HQ
- Seoul, Seoul
Bionsight Questions
Bionsight's website is https://www.bionsight.com/
Bionsight's LinkedIn profile is https://kr.linkedin.com/company/bionsight
Bionsight has
15 employees.
View email and phone details for 15
employees at Bionsight.
Bionsight's industry is
Biotechnology Research
Bionsight's top competitors are
Bio Insight Group,
E-Exhibition,
Bio Design Lab,
Kapal (Korean-American Professional Association In Life Sciences),
Vaxcellbio 박셀바이오,
Solai Inc.,
Beaubrain Healthcare,
Anpoly,
Weflo Inc.,
Bions_cl.
Bionsight's categories are Biotechnology Research
Bionsight's founding year is 2019
